Clinical Trial Update: A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence [Phase 2]

View source ↗

Summary

Phase 2 safety and cognitive function study of encenicline (EVP-6124) versus placebo in nicotine dependence and smoking cessation was terminated; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking Cessation

Drugs mentioned

• EVP-6124

Snippet

Sponsor: A. Eden Evins | Conditions: Nicotine Dependence, Smoking Cessation | Phase 2 | Status: TERMINATED | Results posted: 2017-04-06